Exact Mass: 309.1702

Exact Mass Matches: 309.1702

Found 72 metabolites which its exact mass value is equals to given mass value 309.1702, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fluperlapine

6-fluoro-10-(4-methylpiperazin-1-yl)-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaene

C19H20FN3 (309.1641)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

ISOPROPALIN

ISOPROPALIN

C15H23N3O4 (309.1688)


CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10647; ORIGINAL_PRECURSOR_SCAN_NO 10642 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10600; ORIGINAL_PRECURSOR_SCAN_NO 10598 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10624; ORIGINAL_PRECURSOR_SCAN_NO 10622 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10736; ORIGINAL_PRECURSOR_SCAN_NO 10734 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10608; ORIGINAL_PRECURSOR_SCAN_NO 10605

   

Pro-Pro-Pro

Pro-Pro-Pro

C15H23N3O4 (309.1688)


A tripeptide composed of three L-proline units joined by peptide linkages.

   

Atherosperminine

2-(3,4-Dimethoxyphenanthren-1-yl)-N,N-dimethylethan-1-amine

C20H23NO2 (309.1729)


Atherosperminine is an alkaloid. Atherosperminine is a natural product found in Cryptocarya angulata, Friesodielsia velutina, and other organisms with data available. Atherosperminine is found in fruits. Atherosperminine is an alkaloid from the stem bark of Annona muricata (soursop

   

Zanthosimuline

2,6-dimethyl-2-(4-methylpent-3-en-1-yl)-2H,5H,6H-pyrano[3,2-c]quinolin-5-one

C20H23NO2 (309.1729)


Zanthosimuline is found in fruits. Zanthosimuline is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Zanthosimuline is found in herbs and spices and fruits.

   

Lysyltyrosine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanoic acid

C15H23N3O4 (309.1688)


Lysyltyrosine is a dipeptide composed of lysine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Tyrosyl-Lysine

6-Amino-2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}hexanoate

C15H23N3O4 (309.1688)


Tyrosyl-Lysine is a dipeptide composed of tyrosine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

4-Diphenylacetoxy-n-methylpiperidine

1-Methylpiperidin-4-yl diphenylacetic acid

C20H23NO2 (309.1729)


   

Dexoxadrol

2-(2,2-Diphenyl-1,3-dioxolan-4-yl)piperidine

C20H23NO2 (309.1729)


   

Gevotroline

8-Fluoro-2,3,4,5-tetrahydro-2-[3-(3-pyridinyl)propyl]1H-pyrido[4,3-b]indole

C19H20FN3 (309.1641)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

Pro-Pro-Pro

1-[1-(pyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid

C15H23N3O4 (309.1688)


   

Carbazoquinocin C

Carbazoquinocin C

C20H23NO2 (309.1729)


   

Carbazoquinocin B

Carbazoquinocin B

C20H23NO2 (309.1729)


   

2-[(1-Benzyl-4-piperidyl)amino]-6-fluorobenzonitrile

2-[(1-Benzyl-4-piperidyl)amino]-6-fluorobenzonitrile

C19H20FN3 (309.1641)


   

Maybridge2_000507

Maybridge2_000507

C19H20FN3 (309.1641)


   

17alpha-cyanomethyl-1,3,5(10),9(11)-estratetraene-3,17-diol|17alpha-Cyanomethylestra-1,3,5(10),9(11)-tetraen-3,17beta-diol|J 1201

17alpha-cyanomethyl-1,3,5(10),9(11)-estratetraene-3,17-diol|17alpha-Cyanomethylestra-1,3,5(10),9(11)-tetraen-3,17beta-diol|J 1201

C20H23NO2 (309.1729)


   

dechlorofontomide|Dechlorofontonamide

dechlorofontomide|Dechlorofontonamide

C20H23NO2 (309.1729)


   

4-(3-Methyl-but-2-ene)oxy, N-benzoyl phenethyl amine

4-(3-Methyl-but-2-ene)oxy, N-benzoyl phenethyl amine

C20H23NO2 (309.1729)


   

FLUPERLAPINE

FLUPERLAPINE

C19H20FN3 (309.1641)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

Cypridinid etioluciferin

Cypridinid etioluciferin

C16H19N7 (309.1702)


   
   
   
   

Lys-tyr

6-amino-2-[2-amino-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C15H23N3O4 (309.1688)


A dipeptide formed from L-lysine and L-tyrosine residues.

   

Tyr-lys

2-(2,6-diaminohexanamido)-3-(4-hydroxyphenyl)propanoic acid

C15H23N3O4 (309.1688)


A dipeptide formed from L-tyrosine and L-lysine residues.

   

atherospermine

3,4-Dimethoxy-N,N-dimethyl-1-phenanthreneethanamine, 9CI

C20H23NO2 (309.1729)


   

Zanthosimuline

2,6-dimethyl-2-(4-methylpent-3-en-1-yl)-2H,5H,6H-pyrano[3,2-c]quinolin-5-one

C20H23NO2 (309.1729)


   

Amolanone

Amolanone

C20H23NO2 (309.1729)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Gefitinib impurity 2

Gefitinib impurity 2

C15H23N3O4 (309.1688)


   
   

2,4,6-Triphenyl-1,3,5,2,4,6-triazatriborinane

2,4,6-Triphenyl-1,3,5,2,4,6-triazatriborinane

C18H18B3N3 (309.178)


   

3-[(3,4-dimethylphenyl)methyl]-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione

3-[(3,4-dimethylphenyl)methyl]-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione

C20H23NO2 (309.1729)


   

Carbamic acid, N,N-3,5-pyridinediylbis-, C,C-bis(1,1-dimethylethyl) ester

Carbamic acid, N,N-3,5-pyridinediylbis-, C,C-bis(1,1-dimethylethyl) ester

C15H23N3O4 (309.1688)


   

ethyl anthranilate / cuminaldehyde schiffs base

ethyl anthranilate / cuminaldehyde schiffs base

C20H23NO2 (309.1729)


   

2-(4-tert-butoxycarbonylamino-butylamino)-nicotinic acid

2-(4-tert-butoxycarbonylamino-butylamino)-nicotinic acid

C15H23N3O4 (309.1688)


   

2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate

2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate

C15H23N3O4 (309.1688)


   

5-tert-butyl 3-ethyl 1-methyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-3,5(4H)-dicarboxylate

5-tert-butyl 3-ethyl 1-methyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-3,5(4H)-dicarboxylate

C15H23N3O4 (309.1688)


   

acetic acid,tert-butyl N-(5,6,7,8-tetrahydro-1,7-naphthyridin-3-yl)carbamate

acetic acid,tert-butyl N-(5,6,7,8-tetrahydro-1,7-naphthyridin-3-yl)carbamate

C15H23N3O4 (309.1688)


   

4-(2-PIPERIDYLETHOXY)BENZOPHENONE

4-(2-PIPERIDYLETHOXY)BENZOPHENONE

C20H23NO2 (309.1729)


   

6-methyl-N1-(3-methyl-1-(6-(methylamino)pyrimidin-4-yl)-1H-pyrazol-5-yl)benzene-1,3-diamine

6-methyl-N1-(3-methyl-1-(6-(methylamino)pyrimidin-4-yl)-1H-pyrazol-5-yl)benzene-1,3-diamine

C16H19N7 (309.1702)


   

(1-Ethyl-3-pyrrolidinyl)(diphenyl)acetic acid

(1-Ethyl-3-pyrrolidinyl)(diphenyl)acetic acid

C20H23NO2 (309.1729)


   

Dioxadrol

(2S)-2-[(4S)-2,2-Diphenyl-1,3-dioxolan-4-yl]piperidine

C20H23NO2 (309.1729)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics

   
   

Amino-PEG5-C2-acid

Amino-PEG5-C2-acid

C13H27NO7 (309.1787)


   

N-[1-(2,3-Dihydro-1,4-benzodioxin-2-yl)ethylidene]-alpha-methylbenzenepropanamine

N-[1-(2,3-Dihydro-1,4-benzodioxin-2-yl)ethylidene]-alpha-methylbenzenepropanamine

C20H23NO2 (309.1729)


   

Trans-Methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate

Trans-Methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate

C20H23NO2 (309.1729)


   

2-(2-hex-1-ynylcyclohexyl)isoindole-1,3-dione

2-(2-hex-1-ynylcyclohexyl)isoindole-1,3-dione

C20H23NO2 (309.1729)


   

(3S)-3-Z-AMINO-1-DIAZO-2-BUTANONE

(3S)-3-Z-AMINO-1-DIAZO-2-BUTANONE

C17H24FNO3 (309.174)


   

1-[3-(2-Methoxy-5-nitrophenoxy)propyl]-4-methylpiperazine

1-[3-(2-Methoxy-5-nitrophenoxy)propyl]-4-methylpiperazine

C15H23N3O4 (309.1688)


   

4-(BENZYLOXY)-N-CYCLOHEXAMIDOANILINE

4-(BENZYLOXY)-N-CYCLOHEXAMIDOANILINE

C20H23NO2 (309.1729)


   
   

5-Deoxy-5-Piperidin-1-Ylthymidine

5-Deoxy-5-Piperidin-1-Ylthymidine

C15H23N3O4 (309.1688)


   

Fructosyllysine(1+)

Fructosyllysine(1+)

C12H25N2O7+ (309.1662)


An amino-acid cation comprising fructosyllysine having a deprotonated carboxy group and both amino groups protonated; major species at pH 7.3.

   

Psicosyllysine(1+)

Psicosyllysine(1+)

C12H25N2O7+ (309.1662)


An amino-acid cation comprising psicosyllysine having a deprotonated carboxy group and both amino groups protonated; major species at pH 7.3.

   
   

5-Fluoro-2-[(3S)-1-(2-methylbenzyl)-3-pyrrolidinyl]-1H-benzimidazole

5-Fluoro-2-[(3S)-1-(2-methylbenzyl)-3-pyrrolidinyl]-1H-benzimidazole

C19H20FN3 (309.1641)


   

N-[2-(3-phenoxyphenoxy)ethyl]-N-prop-2-enyl-2-propen-1-amine

N-[2-(3-phenoxyphenoxy)ethyl]-N-prop-2-enyl-2-propen-1-amine

C20H23NO2 (309.1729)


   

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-serinamide

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-serinamide

C15H23N3O4 (309.1688)


   

4-(3-(4-Trimethylsilyloxyphenoxy)propyl)morpholine

4-(3-(4-Trimethylsilyloxyphenoxy)propyl)morpholine

C16H27NO3Si (309.176)


   

Gevotroline

Gevotroline

C19H20FN3 (309.1641)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

4-Diphenylacetoxy-n-methylpiperidine

4-Diphenylacetoxy-n-methylpiperidine

C20H23NO2 (309.1729)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-3-methylbutanamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-3-methylbutanamide

C15H23N3O4 (309.1688)


   

4-(3'-methyl-but-2'-ene)oxy,n-benzoylphenethyl amine

NA

C20H23NO2 (309.1729)


{"Ingredient_id": "HBIN009910","Ingredient_name": "4-(3'-methyl-but-2'-ene)oxy,n-benzoylphenethyl amine","Alias": "NA","Ingredient_formula": "C20H23NO2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14167","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4-(3'-methyl-but-2'-one)oxy,n-benzoyl phenethyl amine

NA

C20H23NO2 (309.1729)


{"Ingredient_id": "HBIN009912","Ingredient_name": "4-(3'-methyl-but-2'-one)oxy,n-benzoyl phenethyl amine","Alias": "NA","Ingredient_formula": "C20H23NO2","Ingredient_Smile": "CC(=CCOC1=CC=C(C=C1)CCNC(=O)C2=CC=CC=C2)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30091","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-3-methylbutanamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-3-methylbutanamide

C15H23N3O4 (309.1688)


   

1-heptyl-2-methyl-9h-carbazole-3,4-dione

1-heptyl-2-methyl-9h-carbazole-3,4-dione

C20H23NO2 (309.1729)


   

n-(7-ethenyl-7,10,10-trimethyl-9-oxo-6,10a-dihydro-5h-anthracen-1-yl)carboximidic acid

n-(7-ethenyl-7,10,10-trimethyl-9-oxo-6,10a-dihydro-5h-anthracen-1-yl)carboximidic acid

C20H23NO2 (309.1729)


   

(2s)-2,6-dimethyl-2-(4-methylpent-3-en-1-yl)pyrano[3,2-c]quinolin-5-one

(2s)-2,6-dimethyl-2-(4-methylpent-3-en-1-yl)pyrano[3,2-c]quinolin-5-one

C20H23NO2 (309.1729)


   

2-methyl-1-(5-methylhexyl)-9h-carbazole-3,4-dione

2-methyl-1-(5-methylhexyl)-9h-carbazole-3,4-dione

C20H23NO2 (309.1729)


   

(2s)-2-{[(2s)-2,6-diamino-1-hydroxyhexylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-{[(2s)-2,6-diamino-1-hydroxyhexylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C15H23N3O4 (309.1688)


   

(1s,12s,13r,14s)-15-ethylidene-7-hydroxy-13-(hydroxymethyl)-3,17λ⁵-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8,16-pentaen-17-ylium

(1s,12s,13r,14s)-15-ethylidene-7-hydroxy-13-(hydroxymethyl)-3,17λ⁵-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8,16-pentaen-17-ylium

[C19H21N2O2]+ (309.1603)


   

n-[(7r,10ar)-7-ethenyl-7,10,10-trimethyl-9-oxo-6,10a-dihydro-5h-anthracen-1-yl]carboximidic acid

n-[(7r,10ar)-7-ethenyl-7,10,10-trimethyl-9-oxo-6,10a-dihydro-5h-anthracen-1-yl]carboximidic acid

C20H23NO2 (309.1729)